Stay updated on Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial page.

Latest updates to the Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial page
- CheckyesterdayChange DetectedFooter revision updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe Related Topics section now includes links for Ovarian cancer and MedlinePlus Genetics. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check23 days agoChange DetectedAdded a footer revision note: 'Revision: v3.3.3'. Removed footer links and references to 'HHS Vulnerability Disclosure', 'Ovarian cancer', and 'MedlinePlus Genetics', as well as 'Revision: v3.3.2'.SummaryDifference0.2%

- Check51 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 in the page header. No substantive changes to the study details or layout.SummaryDifference0.0%

- Check58 days agoChange DetectedThe government funding notice about potential delays and linking to cc.nih.gov and opm.gov has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check73 days agoChange DetectedAdded Ovarian cancer as a related topic and added MedlinePlus Genetics as related topics on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial page.